Otello Stampacchia Buys $29.8M of Windward BIO Group Ag (WWB) — SEC Form 4, Nov 18, 2026

Open-Market Net Purchase · SEC Form 4
+$29,750,000
Reporting Owner
TXN 2026-11-16 · FILED 2026-11-18
Equity Position 5.34M sh 0 → 5,338,520
Insider Cluster 4 buying within 30 days — view cluster
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-18
Report Date
2026-11-18
Accession No.
0001361712-26-000011
Accepted At
2026-11-18 21:30 UTC
Reporting Owner
Name Relationship
Otello Stampacchia CIK 0001361712
Director
Otello Stampacchia at Windward BIO Group Ag Full insider history
Bought (12 mo) $29,750,000
Sold (12 mo) —
More from this insider at Windward BIO Group Ag
2026-11-16 Award — View
All filings by this insider at Windward BIO Group Ag
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common SharesF1 2026-11-16 P - Purchase 875,000 A $17.00 +$14,875,000 875,000 Indirect By Omega Fund VII, L.P.
Common SharesF2 2026-11-16 P - Purchase 875,000 A $17.00 +$14,875,000 875,000 Indirect By Omega Fund VIII, L.P.
Common SharesF3F1 2026-11-16 C - Conversion 1,262,628 A — 2,137,628 Indirect By Omega Fund VII, L.P.
Common SharesF3F2 2026-11-16 C - Conversion 1,262,626 A — 2,137,626 Indirect By Omega Fund VIII, L.P.
Common SharesF3F1 2026-11-16 C - Conversion 531,632 A — 2,669,260 Indirect By Omega Fund VII, L.P.
Common SharesF3F2 2026-11-16 C - Conversion 531,634 A — 2,669,260 Indirect By Omega Fund VIII, L.P.
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Series A Preferred SharesF3F3F3F1 2026-11-16 C - Conversion 1,262,628 D $0.00 1,262,628 Common Shares Indirect By Omega Fund VII, L.P.
Series A Preferred SharesF3F3F3F2 2026-11-16 C - Conversion 1,262,626 D $0.00 1,262,626 Common Shares Indirect By Omega Fund VIII, L.P.
Series B Preferred SharesF3F3F3F1 2026-11-16 C - Conversion 531,632 D $0.00 531,632 Common Shares Indirect By Omega Fund VII, L.P.
Series B Preferred SharesF3F3F3F2 2026-11-16 C - Conversion 531,634 D $0.00 531,634 Common Shares Indirect By Omega Fund VIII, L.P.
Footnotes (3)
F1
Shares held directly by Omega Fund VII, L.P. ("Omega VII"). Omega Fund VII GP, L.P. ("Omega VII GP") is the sole general partner of Omega VII. Omega Fund VII GP Manager, Ltd. ("Omega VII Manager") is the sole general partner of Omega VII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VII Manager and each disclaims beneficial ownership of the shares held by Omega VII except to the extent of his pecuniary interest therein, if any. Show more
F2
Shares held directly by Omega Fund VIII, L.P. ("Omega VIII"). Omega Fund VIII GP, L.P. ("Omega VIII GP") is the sole general partner of Omega VIII. Omega Fund VIII GP Manager, Ltd. ("Omega VIII Manager") is the sole general partner of Omega VIII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VIII Manager and each disclaims beneficial ownership of the shares held by Omega VIII except to the extent of his pecuniary interest therein, if any. Show more
F3
Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1 to 1 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date. Show more
Other insiders at Windward BIO Group Ag
All Windward BIO Group Ag insider activity
GET /v1/forms/4/0001361712-26-000011 API docs
View Original SEC Filing